CLINICAL_TRIALS
trial_result
· 2014-10-08
Clinical Trial Update: Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 trial evaluating the efficacy and safety of DLBS3233 in adults with new-onset type 2 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dexa Medica Group | Conditions: Type-2-diabetes Mellitus, New Onset | Phase 3 | Status: COMPLETED